NHAS
FSTX

Novo Holdings A/S’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Novo Holdings A/S’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,703
Closed -$20K – 52
2021
Q3 		$20K Hold
2,703
– – ﹤0.01% 49
2021
Q2 		$23K Sell
2,703
-32,116
-92% -$274K ﹤0.01% 54
2021
Q1 		$377K Hold
34,819
– – 0.02% 51
2020
Q4 		$344K Buy
+34,819
New +$228K 0.01% 45

Other funds holding FSTX

RCI
Ridgeback Capital Investments Miami Beach, Florida $560K AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Novo Holdings A/S's FSTX Position: Q4 2021 in Review

Novo Holdings A/S sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q4 2021, closing a stake of 2,703 shares — an estimated $20K sold.

Novo Holdings A/S first reported a position in FSTX in Q4 2020 and held it in 4 quarters. The position peaked at $377K in Q1 2021. 43 funds tracked by Wall St. Rank hold FSTX as of Q4 2021.

  • Novo Holdings A/S reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Novo Holdings A/S sold 2,703 F-star Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $20K.
  • Novo Holdings A/S first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • Novo Holdings A/S's F-star Therapeutics, Inc. Common Stock position peaked at $377K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Novo Holdings A/S's 13F filing for Q4 2021, filed 14 Feb 2022.